KRT5 and breast cancer: Given that enrichment for CSC-like features is a well-known molecular hallmark of highly aggressive basal-like BC [45-57], it is reasonable to propose a causal link between the presence of basal markers (e.g., CK5/6), an augmented CSC activity, and primary resistance to trastuzumab in basal-HER2+ disease.